| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/12/2009 | CN100525829C Method for detecting ligands and targets in a mixture |
| 08/11/2009 | US7572885 Isolated GAGE-7B and 8 proteins |
| 08/11/2009 | US7572771 Mimetic that promotes ABCA1-dependent lipid efflux from cells and is substantially non-cytotoxic; dyslipidemic and cardiovascular disorders such as atherosclerosis; ATP-binding cassette transporter A1 (ABCA1) |
| 08/06/2009 | WO2009095456A1 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 08/06/2009 | US20090197315 Fullerene-based amino acids |
| 08/05/2009 | EP2084140A1 Arginine derivatives with np-i antagonistic activity |
| 08/05/2009 | EP2083844A2 Hcv ns3 protease inhibitors |
| 08/05/2009 | EP2083843A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 08/05/2009 | EP1737821B1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 08/05/2009 | EP1587941B1 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 08/05/2009 | EP1420681A4 Peptide-based multimeric targeted contrast agents |
| 08/05/2009 | EP1235595B1 Integrin-mediated drug targeting |
| 08/05/2009 | CN101501061A Macrocyclic compounds as antiviral agents |
| 08/05/2009 | CN101497655A Polypeptide hydration salt compound and use for anti-depression aspect |
| 08/05/2009 | CN101497651A Compound with thrombus dissolving activity, as well as preparation and use thereof |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/04/2009 | US7569711 Enone cancer therapeutics |
| 08/04/2009 | US7569548 Method of preparing peptide |
| 08/04/2009 | US7569351 P53 dependent apoptosis-associated gene and protein |
| 08/04/2009 | US7569229 Monocyte locomotion inhibitory factor |
| 07/30/2009 | WO2009093918A1 A method of producing an n-blocked biphalin intermediate |
| 07/30/2009 | WO2009070631A3 Ethoid compounds for use as food additives |
| 07/30/2009 | WO2007136635A8 Enhancement of radiation therapy and/or chemotherapy with acid ceramidase modulators |
| 07/30/2009 | WO2007110772A8 Immunomodulating oligopeptides |
| 07/30/2009 | US20090192289 Omi pdz modulators |
| 07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
| 07/30/2009 | US20090192092 Neuropeptides and Their Use for Pest Control |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090191600 Via L-aspartic acid- alpha,beta-diester and L-phenylalanine using enzyme that has ability to selectively link L-phenylalanine to alpha -ester site of L-aspartic acid- alpha,beta-diester through peptide bond/nucleophilic attack; easy, high yield and inexpensively without going through a complex synthesis |
| 07/30/2009 | US20090191151 Triazole-containing macrocyclic hcv serine protease inhibitors |
| 07/30/2009 | CA2713005A1 Difluorinated tripeptides as hcv serine protease inhibitors |
| 07/30/2009 | CA2712604A1 Iap inhibitors |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP1761783B1 Identification of compounds modifying a cellular response |
| 07/29/2009 | CN101492494A Integrin ligand cyclic peptide analogues and cyclization method |
| 07/29/2009 | CN100519576C Method for preparing tyr-silk-valine tripeptide |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566765 Heterocyclic compounds containing a nine-membered carbon-nitrogen ring |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566741 Methods of inhibiting osteoclast activity |
| 07/28/2009 | US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 07/28/2009 | US7566697 chemically ligating two oligopeptides, a first oligopeptide thioester having an acidic C-terminal amino acid, having a thioester group, a side chain, side chain protecting group( phenylacryl ester), prevents rearrangements between atoms of the side chain and thioester, with 2nd oligopeptide |
| 07/28/2009 | US7566690 Ace inhibitory peptides from plant materials |
| 07/23/2009 | WO2009092062A2 Fluorescent imaging agents |
| 07/23/2009 | WO2009068351A3 Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k |
| 07/23/2009 | WO2007109648A8 Compositions and methods for modulating store-operated calcium entry |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/23/2009 | US20090186829 Nitrosation-Inducible Inhibitors Biological Macromolecules |
| 07/23/2009 | US20090186825 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186824 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/23/2009 | US20090186422 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT |
| 07/23/2009 | US20090186382 Preparation of Romidepsin |
| 07/23/2009 | CA2749108A1 Fluorescent imaging agents |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2079757A2 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients |
| 07/22/2009 | EP2079756A2 Synthetic peptide amides and dimers thereof |
| 07/22/2009 | EP1501939B1 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/21/2009 | US7563865 Microwave-assisted peptide synthesis |
| 07/21/2009 | US7563863 Plastid transit peptides |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089502A1 Inhibitors of iap |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | WO2007139433A8 Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application |
| 07/16/2009 | WO2007107654A8 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090180981 Quinoxalinyl derivatives |
| 07/16/2009 | US20090180958 Diagnostic and therapeutic agents |
| 07/16/2009 | CA2711606A1 Inhibitors of iap |
| 07/15/2009 | EP2078033A2 Isotopically labeled trapping agent and method for identifying reactive metabolites |
| 07/15/2009 | EP1874329B1 Blood pressure lowering protein hydrolysates |
| 07/15/2009 | EP1866291B1 Antibacterial amide macrocycles vi |
| 07/15/2009 | EP1773868B1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 07/15/2009 | EP1385976B1 Methods for the reduction of stutter in microsatellite amplification using sorbitol |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/09/2009 | WO2009083663A2 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 07/09/2009 | WO2009067225A3 Boceprevir derivatives for the treatment of hcv infections |
| 07/09/2009 | WO2009047728A3 New s-acyl-glutathione derivatives, their syntesis and use in the treatment of oxidative stress-related diseases |
| 07/09/2009 | US20090176967 Conjugation of FVII |
| 07/09/2009 | US20090176964 Stabilized Alpha Helical Peptides and Uses Thereof |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175870 Ykl-40 monoclonal authority |
| 07/09/2009 | US20090175824 Peptides for the treatment of HCV infections |
| 07/09/2009 | US20090175822 C5-substituted, proline-derived, macrocyclic hepatitis c serine protease inhibitors |
| 07/09/2009 | CA2701991A1 Cyclic peptides comprising at least one aza-.beta.3-aminoacyl residue and uses thereof |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
| 07/08/2009 | EP2076278A2 Hcv ns3 protease inhibitors |
| 07/08/2009 | EP2076276A2 Sol-gel materials for cellular modulation |
| 07/08/2009 | EP1781310A4 Articles of peptide nanostructures and method of forming the same |
| 07/08/2009 | EP1682074A4 Compositions and methods for healthy pregnancy |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | CN101479292A Method for purification of oligopeptide |
| 07/08/2009 | CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease |